QC
ELV icon

Quantessence Capital’s Elevance Health ELV Stock Holding History

Quantessence Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,729
Closed -$673K – 218
2025
Q2 		$673K Sell
1,729
-771
-31% -$310K 0.2% 102
2025
Q1 		$1.09M Buy
+2,500
New +$1M 0.27% 82

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Quantessence Capital's ELV Position: Q3 2025 in Review

Quantessence Capital sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,729 shares — an estimated $673K sold.

Quantessence Capital first reported a position in ELV in Q1 2025 and held it in 2 quarters. The position peaked at $1.09M in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Quantessence Capital reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Quantessence Capital sold 1,729 Elevance Health shares in Q3 2025, an estimated $673K.
  • Quantessence Capital first reported a position in Elevance Health in Q1 2025 and held it in 2 quarters.
  • Quantessence Capital's Elevance Health position peaked at $1.09M in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Quantessence Capital's 13F filing for Q3 2025, filed 14 Nov 2025.